Ethyl [1,4'-bipiperidine]-4-carboxylate is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmaceutical compounds. Its structure is particularly valuable in the development of drugs targeting the central nervous system, where it serves as a building block for creating molecules with potential antipsychotic, antidepressant, or analgesic properties. Additionally, it is employed in research focused on designing and optimizing compounds with receptor-binding affinity, particularly for dopamine and serotonin receptors. The compound's versatility also extends to its use in organic synthesis, where it aids in the preparation of complex heterocyclic structures for further pharmacological evaluation.